Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
851B Gel for Cervical High Risk HPV Infection
NCT00312286Phase 2Terminated
- Sponsor
- Takeda
- Start
- Apr 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of epetirimod in human papillomavirus infection, sponsored by Takeda. Started Apr 2006; status: terminated.
02
Drugs
epetirimod
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00312286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312286.